Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type 2 inflammation in asthma and other airway diseases
Jorge Máspero, Yochai Adir, Mona Al‐Ahmad, et al.
ERJ Open Research (2022) Vol. 8, Iss. 3, pp. 00576-2021
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
Surya P. Bhatt, Klaus F. Rabe, Nicola A. Hanania, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 24, pp. 2274-2283
Closed Access | Times Cited: 58
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
David J. Jackson, Michael E. Wechsler, Daniel J. Jackson, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 17
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach
Oliver Pfaar, Anju T. Peters, Camille Taillé, et al.
Clinical and Translational Allergy (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Ginsenosides from Panax ginseng as Key Modulators of NF-κB Signaling Are Powerful Anti-Inflammatory and Anticancer Agents
Won Young Jang, Ji Yeon Hwang, Jae Youl Cho
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6119-6119
Open Access | Times Cited: 39
Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases
Brian Kim, Marc E. Rothenberg, Xin Sun, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 4, pp. 879-893
Open Access | Times Cited: 35
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3371-3371
Open Access | Times Cited: 27
Exhaled Nitric Oxide as Biomarker of Type 2 Diseases
Mauro Maniscalco, Salvatore Fuschillo, Ilaria Mormile, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2518-2518
Open Access | Times Cited: 24
Type-2 inflammation and lung function decline in chronic airway disease in the general population
Yunus Çolak, Shoaib Afzal, Jacob Louis Marott, et al.
Thorax (2024), pp. thorax-220972
Open Access | Times Cited: 15
Type 2 airway inflammation in COPD
Francesca Polverino, Don D. Sin
European Respiratory Journal (2024) Vol. 63, Iss. 5, pp. 2400150-2400150
Closed Access | Times Cited: 11
Advances in Non-Type 2 Asthma in the Severe Cases: from molecular insights to novel treatment strategies
Tao Liu, Prescott G. Woodruff, Xiaobo Zhou
European Respiratory Journal (2024) Vol. 64, Iss. 2, pp. 2300826-2300826
Closed Access | Times Cited: 10
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?
Francesco Giombi, Gian Marco Pace, Francesca Pirola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 730-730
Open Access | Times Cited: 9
Comparative analysis of C-Reactive protein levels among Non-comorbid, Comorbid, and Multimorbid Hospitalized COVID-19 patients
Maria Shoukat, Haseeb Khan, Moona Nazish, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial
Mario Castro, Alberto Papi, Celeste Porsbjerg, et al.
The Lancet Respiratory Medicine (2025)
Closed Access | Times Cited: 1
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
Philippe Gevaert, Martin Desrosiers, Marjolein Cornet, et al.
The Lancet (2025)
Closed Access | Times Cited: 1
Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease
Dimitrios Toumpanakis, Κonstantinos Bartziokas, Agamemnon Bakakos, et al.
Pulmonary Therapy (2025)
Open Access | Times Cited: 1
Immunomodulatory properties of mesenchymal stem cells: A potential therapeutic strategy for allergic rhinitis
Ming Wang, Ning Zhao, Chengshuo Wang, et al.
Allergy (2023) Vol. 78, Iss. 6, pp. 1425-1440
Open Access | Times Cited: 20
Sense of smell in chronic rhinosinusitis: A multicentric study on 811 patients
Alberto Macchi, Alessia Giorli, Elena Cantone, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 20
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence
Marco Caminati, Claudio Micheletto, Francesca Norelli, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 1-2, pp. 15-23
Closed Access | Times Cited: 7
Edaravone alleviated allergic airway inflammation by inhibiting oxidative stress and endoplasmic reticulum stress
Guiping Zhu, Yingying Zeng, Wenjun Peng, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176317-176317
Closed Access | Times Cited: 7
Exploring the immunopathology of type 2 inflammatory airway diseases
Shaimaa Albloushi, Mona Al‐Ahmad
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Novel Serum Biomarkers for Patients with Allergic Asthma Phenotype
Jolita Palačionytė, Andrius Januškevičius, Egle Vasyle, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 232-232
Open Access | Times Cited: 6
Gut Mycobiome and Asthma
Amjad Kanj, Joseph H. Skalski
Journal of Fungi (2024) Vol. 10, Iss. 3, pp. 192-192
Open Access | Times Cited: 6
Dietary Fiber‐Derived Microbial Butyrate Suppresses ILC2‐Dependent Airway Inflammation in COPD
Min Jiang, Jing Wang, Zheng Li, et al.
Mediators of Inflammation (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 5
Trim31 deficiency exacerbates airway inflammation in asthma by enhancing the activation of the NLRP3 inflammasome
Jing Xue, Chunyan Jiang, Xue Chen, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112591-112591
Closed Access | Times Cited: 5
Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System
Felisbela Gomes, Shih-Lung Cheng
Biomolecules (2023) Vol. 13, Iss. 3, pp. 476-476
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top